Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

regulatory affairs Press Releases

  + XML/RSS  



By Q1 Productions
Helping Regulatory Affairs Executives around the World Remain Current on Evolving Regulatory Guidance within the Device & Diagnostic Industries, from Securing Regulatory Approval to Meeting Post-Market Vigilance Requirements

By SFL Regulatory Affairs & Scientific Communication
SFL experts will present on EU medical device/IVD law, public & regulatory affairs synergies and transparency of payments to the healthcare sector

By SFL Regulatory Affairs & Scientific Communication
SFL’s Managing Director, Shayesteh Fürst-Ladani will be giving presentations at two upcoming Swiss life science events on revision of EU Medtech legislation.

By SFL Regulatory Affairs & Scientific Communication
SFL’s Managing Director provides regulatory insight into Drug Device Combination Products in Europe.

By Compliance Trainings
Scheduled On : Thursday, July 18, 2013 at 1:00 PM EDT Duration : 60 Minutes

By MakroCare
MakroCare, an international Drug Development and Commercialization services firm will be exhibiting at DIA-2013, Boston, Massachusetts.

By SFL Regulatory Affairs & Scientific Communication
SFL to attend the DIA 49th Annual Meeting (Booth 1744) in Boston June 23-27, 2013.

By SFL Regulatory Affairs & Scientific Communication
Shayesteh Fürst-Ladani will speak at the Market Access Preliminary Skills for Regulatory Professionals event.

By SFL Regulatory Affairs & Scientific Communication
SFL is pleased to announce the constitution of its company Advisory Board.

By SFL Regulatory Affairs & Scientific Communication
SFL's Managing Director invited to speak at biotech workshop in Germany

By SFL Regulatory Affairs & Scientific Communication
SFL team showcase expertise in Regulatory Affairs, Public Affairs, Legal Services and Medical Communications at the 2013 DIA Annual EuroMeeting in Amsterdam.

By SFL Regulatory Affairs & Scientific Communication
Shayesteh Fürst-Ladani, SFL’s Managing Director, will give a presentation on the classification and regulation of drug/device combinations at the MEDTEC Europe event to be held in Stuttgart, Germany from 26 to 28 February 2013.

By SFL Regulatory Affairs & Scientific Communication
SFL’s team to provide delegates with an understanding of the regulatory framework for drug/device combinations and drug/companion diagnostics in the EU

By Cambridge Healthtech Institute
Badri Rengarajan, M.D., Medical Director, will present in the modeling and simulation tools to improve Phase III success session.

All Press Releases

By Q1 Productions
Helping Regulatory Affairs Executives around the World Remain Current on Evolving Regulatory Guidance within the Device & Diagnostic Industries, from Securing Regulatory Approval to Meeting Post-Market Vigilance Requirements

By GlobalSubmit
Software Release Includes New Module 1 Specifications, Performance Enhancements

By SFL Regulatory Affairs & Scientific Communication
SFL experts will present on EU medical device/IVD law, public & regulatory affairs synergies and transparency of payments to the healthcare sector

By SFL Regulatory Affairs & Scientific Communication
SFL’s Managing Director, Shayesteh Fürst-Ladani will be giving presentations at two upcoming Swiss life science events on revision of EU Medtech legislation.

By SFL Regulatory Affairs & Scientific Communication
SFL’s Managing Director provides regulatory insight into Drug Device Combination Products in Europe.

By ELC Group
World-renowned clinical scientist John Warren joins ELC GROUP’s Advisory Board

By MakroCare
MakroCare expands CPC (Clinical Processing Center), it offers centralized, regional or local clinical processing services to biopharmaceutical and device companies.

By Environmental Systems
Why hire expensive full time technical employees when part time contract employees can complete the necessary tasks and keep your company in compliance with federal and state laws.

By MakroCare
MakroCare today announced the addition of Vistaar, a Regulatory Intelligence tool, to it's RA portfolio. Reg Intel was always the foundation of MakroCare services, with Vistaar, it’s formalized as a tool that it’s customers can benefit from.

By MakroCare
Makrocare, a global specialized consulting partner with extensive expertise in emerging region strategic design, regulatory compliance is sponsoring and exhibiting at RAPS.

By Compliance Trainings
Scheduled On : Thursday, July 18, 2013 at 1:00 PM EDT Duration : 60 Minutes

By MakroCare
MakroCare, an international Drug Development and Commercialization services firm will be exhibiting at DIA-2013, Boston, Massachusetts.

By SFL Regulatory Affairs & Scientific Communication
SFL to attend the DIA 49th Annual Meeting (Booth 1744) in Boston June 23-27, 2013.

By SFL Regulatory Affairs & Scientific Communication
Shayesteh Fürst-Ladani will speak at the Market Access Preliminary Skills for Regulatory Professionals event.

By ELC Group
ELC Group approved by Romanian Medical Agency (NAMMD) to conduct Patient Information Leaflet (PIL) Readability Testing for products targeting Romanian market

By SFL Regulatory Affairs & Scientific Communication
SFL is pleased to announce the constitution of its company Advisory Board.

By SFL Regulatory Affairs & Scientific Communication
SFL's Managing Director invited to speak at biotech workshop in Germany

By SFL Regulatory Affairs & Scientific Communication
SFL team showcase expertise in Regulatory Affairs, Public Affairs, Legal Services and Medical Communications at the 2013 DIA Annual EuroMeeting in Amsterdam.

By ELC Group
ELC Group experts speaking at two-day seminar dedicated to marketing authorisation holders and regulatory affairs professionals

By ELC Group
ELC Group now offering comprehensive range of consultancy and support services for clinical trials

By SFL Regulatory Affairs & Scientific Communication
Shayesteh Fürst-Ladani, SFL’s Managing Director, will give a presentation on the classification and regulation of drug/device combinations at the MEDTEC Europe event to be held in Stuttgart, Germany from 26 to 28 February 2013.

By ELC Group
Unique two-day training event will deliver expert updates on latest European and South Asian regulatory landscape

By marcus evans
Interview with Cheryl Shea-Frederick, Director, Regulatory Affairs at ArthroCare Corporation

By ELC Group
ELC Group boosts support for customers across South East Asian region with new regional office

By marcus evans
Interview with Tatyana Chorny, Regulatory Affairs, Post-Market Surveillance & Complaints Management at Philips Healthcare

By SFL Regulatory Affairs & Scientific Communication
SFL Regulatory Affairs & Scientific Communication Ltd (SFL) has been selected as a finalist in the 2012 British-Swiss Business Awards.

By SFL Regulatory Affairs & Scientific Communication
Shayesteh Fürst-Ladani, Managing Director of the SFL will speak on European Day at the World Medtech Forum in Lucerne, Switzerland.

By SFL Regulatory Affairs & Scientific Communication
SFL’s team to provide delegates with an understanding of the regulatory framework for drug/device combinations and drug/companion diagnostics in the EU

By ELC Group
ELC Group continues Indian expansion with move to new, larger offices in key regional centre

By Online Compliance Panel
All medical device manufacturers are required to comply with the complaint handling requirements and medical device reporting (MDR) pursuant to the applicable statutes and regulations.

By ELC Group
ELC Group expands India presence with new operation at heart of world’s largest pharmaceutical hub

By BioPharm Systems
Leading provider of Oracle's clinical trial, data, and dug safety software will discuss why and how Empirica Topics should be implemented and used to strengthen an organization’s pharmacovigilance systems and processes.

By ELC Group
Opening of new global base follows year of exceptional revenue growth

By Cambridge Healthtech Institute
Badri Rengarajan, M.D., Medical Director, will present in the modeling and simulation tools to improve Phase III success session.

By Nisha Karim
Synowledge is a global provider of drug safety, regulatory affairs and related IT solutions to small, mid and large sized pharmaceutical and biotechnology companies.

By Helix Research Center Ltd
The Educational Services division of UK based MNC,Helix Research Center has announced Clinical Research Certificate Courses with 6 months Internship for the Life Sciences aspirants in all major cities in India

By ELC Group
ELC GROUP Advisory Board’s Dr. Paolo Biffignandi to write opinion column for industry leading publication

By Helix Research Center Ltd
Africa Health Research Organisation and Helix Research Center have announced Clinical Research Training Programs for the Life Sciences Aspirants and Corporates in the Africa and Europe

By Sentrx
Sentrx, the leading provider of drug safety services to the life sciences industry, is pleased to announce the promotion of Michael O’Gorman from CFO to President & General Manager, effective immediately.

By ELC Group
World-renowned physician Dr. Paolo Biffignandi joins ELC GROUP’s Advisory Board

By Diapharm
Manufacturers and registration holders of traditional herbal medicinal products (THRs) agreed to join forces in an association whose functions would include campaigning for the safety of herbal medicinal products.

By BioPharm Systems
Leading provider of Oracle’s clinical trial, data, safety, and pharmacovigilance systems will discuss the new Individual Case Safety Report (ICSR) international standard and upcoming reporting changes, and how to comply with them using Argus Safety

By Regulatory Resources Group
Regulatory Resources Group (RRG), Surrey, England recently won the support category at the inaugural Regulatory Affairs Awards ceremony during a Gala Dinner at the TOPRA Annual Symposium in London.

By Helix Research Center Ltd
Educational Services Division of UK based MNC,Helix Research Center has announced Coorespondence Certificate Courses in Clinical Reseatch for the Doctors,Nurses,CRAs,CRCs and Life Sciences Aspirants seeking Careers in Clinical Research Worldwide

By Helix Research Center Ltd
UK based MNC,Helix Research Center has announced CRO and GCP Training Services for the Global Biopharmaceutical,Medical Device ,Cosmetic Industry,WHO,NIH etc and Clinical Reseatch Professionals respectively in BRICS Nations

By Helix Research Center Ltd
Portugal based Yabulu and United Kingdom based Helix Research Center Ltd have announced Pharmacovigilance Training Programs,both for Freshers as well as working Professionals Worldwide.

By Helix Research Center Ltd
Helix Research Center Ltd has announced Clinical Research Corporate Training Offerings Worldwide ,for Pharmaceutical,Biotechnology,Medical Device and Cosmetic companies ,Investigative Sites,Ethics Committees ,Govt ,Non Govt bodies doing Research.

By Jitto Thomas
"These short term training programs are quite helpful for the professionals and students in the clinical research and quality assurance field, who can't attend regular training programs.",said Mr.Kamal Shahani, Director Cliniminds.

By Jonathan Hart-Smith
Samantha Ng, Senior Recruitment Consultant joins CK Clinical heading up the Regulatory Affairs recruitment Team. Having worked in the Pharmaceutical recruitment field since 2003, Sam is a real asset to the team.

By Visiongain Ltd.
Pharmacovigilance gaining in importance after Vioxx problems-our new report analyses post-marketing assessment from the present onwards-Pharmacovigilance has been expanding in recent years, as companies are required to monitor drug safety post launch



Page:

Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share